alexa Abstract | Polymyxin B hemoperfusion improves hemodynamic status in patients with sepsis with both gram-negative and nongram- negative bacteria

Journal of Clinical & Experimental Nephrology
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article Open Access

Abstract

Background: Direct hemoperfusion with a polymyxin B (PMX) often produces improvement in patients with sepsis caused by bacteria other than those classified as gram-negative. The aim of the present study is to clarify the therapeutic effects of PMX in patients with sepsis caused by bacteria other than gram-negative bacteria.

Methods and Findings: We enrolled 41 patients with severe sepsis including various other diseases, which were treated with PMX. We evaluated the improvement in blood pressure, vasopressor requirement, respiratory condition, Sequential Organ Failure Assessment (SOFA), inotropic score, and serum biochemical markers before and after PMX therapy. PMX therapy improved inotropic scores (14.3 to 8.4, p?0.01) and small decrease partial SOFA scores (2.8 to 2.1, p?0.01). We compared hemodynamic scores between patients with gram-negative bacteria (GN group) and non-gram-negative bacteria (non-GN group). Changes in blood pressure, inotropic score and partial SOFA scores by PMX therapy showed no significant differences between the GN and non-GN groups (p = 0.26, p = 0.11 and
p = 0.3, respectively). Furthermore, we compared the 28-day mortality between GN and non-GN groups. As a result, there is no significant deference. (p = 0.85).

Conclusion: PMX therapy is effective to improve hemodynamic status of septic patients not only with gram-negative but with non-gram-negative bacteria. Main limitation is that the sample size was relatively small and the study was performed in a single center.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Yoichiro Tanaka Kazuhiro Okano Ken Tsuchiya Masakazu Yamamoto and Kosaku Nitta

Keywords

polymyxin B, endotoxin, non-gram-negative bacteria, inotropic score, SOFA score, 28-day mortality, Peritoneal Dialysis, Kidney Diseases, Acute Renal Replacement Therapy, Chronic Kidney Disease, End-Stage Renal Diseases, Glomerulonephritis, Lupus Nephritis, Renal Transplantation, Renal Necrosis, Nephrosclerosis, Renal Impairment, Kidney Failure, Prevention Of Kidney Diseases, Diagnosis And Management Of Kidney Diseases, Diabetic Nephropathy

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us